迈威生物-U
(688062)
| 流通市值：71.26亿 | | | 总市值：139.46亿 |
| 流通股本：2.04亿 | | | 总股本：4.00亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,722,336,051.32 | 1,650,895,457.76 | 1,755,105,228.76 | 2,028,921,701.3 |
| 应收票据及应收账款 | 22,746,899.88 | 17,510,210.05 | 6,359,760.18 | 11,092,657.27 |
| 应收账款 | 22,746,899.88 | 17,510,210.05 | 6,359,760.18 | 11,092,657.27 |
| 预付款项 | 35,014,400.87 | 26,596,108.14 | 35,258,440.25 | 37,382,643.46 |
| 其他应收款合计 | 119,989,871.09 | 112,265,995.71 | 38,580,742.32 | 32,535,187.23 |
| 存货 | 155,668,938.62 | 159,299,441 | 152,847,845.26 | 133,386,817.56 |
| 其他流动资产 | 85,526,796.39 | 66,144,149.01 | 110,622,102.6 | 96,087,858.61 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,217,103,319.76 | 2,047,592,313.46 | 2,149,595,299.69 | 2,400,226,320.87 |
| 非流动资产: | | | | |
| 长期股权投资 | 43,424,300.1 | 41,950,326.49 | 20,364,640.25 | 20,580,844.82 |
| 固定资产 | 603,173,398.06 | 622,789,554.08 | 410,150,171.52 | 420,208,054.42 |
| 在建工程 | 1,165,365,122.82 | 1,130,700,157.39 | 1,229,553,292.65 | 1,183,593,187.77 |
| 使用权资产 | 175,334,954.99 | 181,562,202.31 | 167,702,534.94 | 174,840,799.29 |
| 无形资产 | 134,587,710.37 | 139,720,169.43 | 148,048,227.62 | 153,158,473.84 |
| 商誉 | 118,769,811.89 | 118,769,811.89 | 118,769,811.89 | 118,769,811.89 |
| 长期待摊费用 | 433,477.01 | 983,331.14 | 2,196,147.86 | 3,506,359.46 |
| 其他非流动资产 | 183,623,196.15 | 170,980,574.52 | 204,152,024.23 | 175,713,073.47 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,424,711,971.39 | 2,407,456,127.25 | 2,300,936,850.96 | 2,250,370,604.96 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,641,815,291.15 | 4,455,048,440.71 | 4,450,532,150.65 | 4,650,596,925.83 |
| 流动负债: | | | | |
| 短期借款 | 677,188,791.84 | 209,267,627.79 | 110,003,236.12 | 100,093,611.12 |
| 交易性金融负债 | 3,442,098.39 | 3,442,098.39 | - | - |
| 应付票据及应付账款 | 44,482,987.11 | 62,317,377.83 | 52,462,804.84 | 55,236,448.26 |
| 应付账款 | 44,482,987.11 | 62,317,377.83 | 52,462,804.84 | 55,236,448.26 |
| 合同负债 | 15,079,514.75 | 13,518,550.15 | 30,679,922.67 | 30,647,617.68 |
| 应付职工薪酬 | 39,831,793.27 | 74,486,423.75 | 67,087,930.13 | 51,936,492.2 |
| 应交税费 | 27,170,858.32 | 31,166,879.69 | 4,063,173.45 | 4,805,582.98 |
| 其他应付款合计 | 204,627,044.41 | 393,634,236.06 | 222,860,760.24 | 241,079,450.64 |
| 一年内到期的非流动负债 | 39,653,294.8 | 28,553,574.12 | 24,314,472.64 | 16,528,535.67 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,051,476,382.89 | 816,386,767.78 | 511,472,300.09 | 500,327,738.55 |
| 非流动负债: | | | | |
| 长期借款 | 1,022,315,828.62 | 887,715,828.62 | 863,520,795.84 | 824,809,302.81 |
| 租赁负债 | 158,387,124.49 | 167,105,781.06 | 150,684,831.75 | 160,692,014.67 |
| 预计负债 | - | - | - | 213,700 |
| 递延收益 | 13,932,500 | 10,592,000 | 10,701,500 | 10,811,000 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,194,635,453.11 | 1,065,413,609.68 | 1,024,907,127.59 | 996,526,017.48 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,246,111,836 | 1,881,800,377.46 | 1,536,379,427.68 | 1,496,853,756.03 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 399,600,000 | 399,600,000 | 399,600,000 | 399,600,000 |
| 资本公积 | 5,959,191,991.49 | 5,930,649,018.13 | 5,887,815,831 | 5,865,937,413.56 |
| 其他综合收益 | 4,925,414.14 | 4,802,329.54 | 6,347,832.62 | 7,139,975.7 |
| 未分配利润 | -3,957,007,981.07 | -3,751,349,456.68 | -3,371,203,295.52 | -3,111,441,835.44 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,406,709,424.56 | 2,583,701,890.99 | 2,922,560,368.1 | 3,161,235,553.82 |
| 少数股东权益 | -11,005,969.41 | -10,453,827.74 | -8,407,645.13 | -7,492,384.02 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,395,703,455.15 | 2,573,248,063.25 | 2,914,152,722.97 | 3,153,743,169.8 |
| 负债和股东权益合计 | 4,641,815,291.15 | 4,455,048,440.71 | 4,450,532,150.65 | 4,650,596,925.83 |
| 公告日期 | 2024-04-30 | 2024-04-09 | 2023-10-26 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |